A lipohypertrophic node feels like a soft, rubbery lump under the skin where you've been injecting for months. It's painless, which is why it goes unnoticed — and it makes the next injection into that site absorb anywhere from 50% to 120% of what the previous one did.
Lipohypertrophy presents as a soft, painless thickening of subcutaneous tissue at frequently-used injection sites. The skin above looks normal; the lump is felt by pressing flat with the side of the hand. It's firmer than surrounding fat and often the size of a grape. It is not:
Healthy subcutaneous tissue has a regular capillary bed that absorbs at a roughly predictable rate per cm². Lipohypertrophic tissue has hypertrophied adipocytes, focal fibrosis, and a disrupted capillary network. The same volume of injected peptide can sit in the tissue for hours longer than at a healthy site, or pool and be absorbed in a burst.
On insulin this shows up as glucose readings that wander 30–40% from prediction. On weekly GLP-1s it's harder to notice because the effect is averaged over a week, but the day-to-day fullness response can swing.
Lipohypertrophy is caused by repeated injection trauma to the same patch of tissue. Three factors compound:
The proximate cause is the local growth-factor effect of the peptide itself (insulin and GLP-1s both promote adipocyte growth at the local pool), combined with chronic micro-trauma. The fix has to address all three.
Divide the abdomen into 8 zones (4 upper quadrants, 4 lower quadrants on each side of the midline). Use a different zone each week, returning to the same zone no sooner than every 8 weeks. Within a zone, vary the exact spot by 2–3 cm.
| Body region | Best for | Rotation tax |
|---|---|---|
| Abdomen (avoid 2 cm around navel) | Weekly GLP-1, most consistent absorption | Lowest — 8 zones easily |
| Thighs (anterolateral, mid-portion) | Daily insulin, secondary GLP-1 | Medium — 4 zones per thigh |
| Upper arms (deltoid, posterior) | Less subcutaneous fat; need helper | Highest — 2 zones per arm |
| Buttocks | Backup site, harder to inject solo | Medium |
A lipohypertrophic node needs ≥3 months without injection into that zone to soften. Some nodes never fully resolve and remain palpable for years — they just stop being the site of new injections. Massage and ultrasound have no evidence for accelerating resolution. Time and avoidance are the only treatments.
No. The damaged tissue will get worse, absorption will continue to be unreliable, and recovery will not begin until you stop. The "convenience" gain is offset by erratic dose effect.
No. The cause is repetition and trauma, not cold or skin flora. Site rotation and fresh needles are the only proven prevention.
In practice, yes — weekly versus daily means fewer repetitions. But "less likely" is not "won't." Multi-year GLP-1 users on weekly injections can develop palpable nodes if they don't rotate.
Yes, eventually. The hypertrophied tissue softens over months. The patch may remain slightly thicker than surrounding tissue for years but absorption normalizes.
Peptide Protocol's rotation engine remembers every injection by zone and tells you exactly where the next one should go.
Get the iPhone app →Informational and educational only. Not medical advice. Consult a licensed clinician before starting, changing, or stopping any peptide protocol. Mentions of investigational, compounded, or research-use peptides are for informational purposes; many such substances are not FDA-approved for human use.